First human trial for new drug ORKA-001 begins safety check
Knowledge-focused
Completed
This early-phase study tested a single injection of ORKA-001 in 24 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo. The main goal was to check for side effects and changes in vital sign…
Phase: PHASE1 • Sponsor: Oruka Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC